Revolutionizing Aesthetics: Allergan Aesthetics' Innovation Pipeline and Future Focus Areas

Focus Areas

Our team of scientists is pioneering new solutions based on solid evidence, targeting innovative indications and improved delivery technologies to enhance patient outcomes in the field of aesthetic medicine.

Building upon decades of leadership in aesthetic medicine, what's next?

We are dedicated to creating comprehensive products and technologies that advance this medical aesthetics industry. Conducting indepent research, development, and manufacturing, our goal is to discover and accelerate science-driven solutions that enrich people's lives.

Analyzing data, identifying trs, and extracting insights allow us to offer one of the largest, most-researched portfolios in the medical aesthetics sector.

Our RD team at the Irvine, California site is pushing boundaries in aesthetic medicine drug discovery and development.

The integration of Allergan into AbbVie since 2020 has significantly strengthened our capacity to find solutions for patients. Our combined innovation, technology expertise, and scientific prowess are being harnessed to achieve ambitious goals - something evident in our evolving product pipeline.

Dr. Darin Messina

Senior Vice President, RD Allergan Aesthetics, an AbbVie company

RELEVANT CONTENT

Allergan Aesthetics published “The Future of Aesthetics” global trs report.

Explore career opportunities.

Our approach to combating signs of aging is evidence-based and med at defining the standard of care through a portfolio of complementary solutions that redefine the aesthetic industry. Our focus areas include:

• Advancing neurotoxin therapy, leveraging decades of experience in both cosmetic and therapeutic applications by prioritizing new indications and diversifying formulations, serotypes, and durations.

• Evolving dermal filler science, developing innovative injectables to address signs of aging caused by structural loss on the skin and underlying tissues.

• Exploring advancements in non-invasive body contouring for localized fat reduction, body sculpting, core strengthening, and cellulite treatments with potential areas like skin laxity and scar management.

• Leading industry innovation in plastic surgery and regenerative medicine, driving progress in implantable medical devices while focusing on technologies that promote tissue rebuilding and regeneration as a critical breakthrough for patients seeking reconstruction after surgeries.

• Expanding our comprehensive portfolio of topical skincare offerings to address diverse skin types and new benefit areas, based on rigorous research backed by consumer demand for solutions for conditions like hyperpigmentation and acne.

JOIN US

Explore career opportunities with us in this cutting-edge aesthetics field.
This article is reproduced from: https://www.abbvie.ch/en/science/areas-of-focus/aesthetics.html

Please indicate when reprinting from: https://www.623n.com/Plastic_surgery_hospital/Aesthetic_Leaders_in_Science_and_Technology.html